0001209191-11-023116.txt : 20110418
0001209191-11-023116.hdr.sgml : 20110418
20110418123038
ACCESSION NUMBER: 0001209191-11-023116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20101001
FILED AS OF DATE: 20110418
DATE AS OF CHANGE: 20110418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lindell Jody S
CENTRAL INDEX KEY: 0001356151
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 11764945
MAIL ADDRESS:
STREET 1: 2536 FILLMORE ST.
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2010-10-01
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001356151
Lindell Jody S
C/O PDL BIOPHARMA, INC.
932 SOUTHWOOD BOULEVARD
INCLINE VILLAGE
NV
89451
1
0
0
0
Common Stock
2010-10-01
4
P
0
285
5.2614
A
20168
D
Common Stock
2011-03-15
4
P
0
89
5.5291
A
20257
D
These shares were acquired pursuant to an automatic dividend reinvestment feature managed by the reporting person's investment advisor.
/s/Christopher Stone, Attorney-in-Fact for Jody S. Lindell
2011-04-18